Glenmark Life Sciences Limited (GLS.BO)
INR 1021.7
(-0.42%)
INR 1021.7
(-0.42%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 22.83 Billion | 20.47 Billion | 20.87 Billion | 18.61 Billion | 14.94 Billion | 13.6 Billion |
| Cost of Revenue | 10.39 Billion | 10.31 Billion | 10.57 Billion | 9.15 Billion | 7.02 Billion | 6.28 Billion |
| Gross Profit | 12.43 Billion | 10.16 Billion | 10.29 Billion | 9.45 Billion | 7.91 Billion | 7.32 Billion |
| Operating Expenses | 11.64 Billion | 4.15 Billion | 4.5 Billion | 3.83 Billion | 3.47 Billion | 3.22 Billion |
| Selling, General and Administrative Expenses | 395.61 Million | 337.68 Million | 309.77 Million | 412.84 Million | 334.89 Million | 359.56 Million |
| Research and Development Expenses | 752.97 Million | 651.77 Million | 571.96 Million | 2.9 Million | 400.28 Million | 1.44 Million |
| Other Expenses | 11.24 Billion | 1.68 Million | 3.19 Million | 3.81 Million | 3.96 Million | 330 Thousand |
| Cost and Expenses | 13.85 Billion | 14.47 Billion | 15.08 Billion | 12.99 Billion | 10.5 Billion | 9.51 Billion |
| Operating Income | 8.97 Billion | 5.97 Billion | 5.77 Billion | 5.54 Billion | 4.18 Billion | 2.02 Billion |
| Interest Expense | 15.46 Million | 5.47 Million | 279.62 Million | 875.47 Million | 335.15 Million | 6.05 Million |
| Income Tax Expense | 1.6 Billion | 1.61 Billion | 1.46 Billion | 1.19 Billion | 1.07 Billion | 1.11 Billion |
| Earnings before Tax | 6.31 Billion | 6.28 Billion | 5.64 Billion | 4.7 Billion | 4.21 Billion | 4.03 Billion |
| Net Income | 4.7 Billion | 4.66 Billion | 4.18 Billion | 3.51 Billion | 3.13 Billion | 2.92 Billion |
| Earnings Per Share Basic | 38.43 | 38.11 | 35.63 | 32.61 | 29.04 | 23.89 |
| Earnings Per Share Diluted | 38.38 | 38.11 | 35.63 | 32.61 | 29.04 | 23.89 |
| Weighted Average Shares Outstanding | 122.52 Million | 122.52 Million | 117.52 Million | 107.8 Million | 107.8 Million | 122.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 122.69 Million | 122.52 Million | 117.53 Million | 107.8 Million | 107.8 Million | 122.52 Million |
| Gross Margin | 0.54 | 0.50 | 0.49 | 0.51 | 0.53 | 0.54 |
| EBIT Margin | 0.30 | 0.33 | 0.30 | 0.32 | 0.32 | 0.32 |
| Profit Margin | 0.21 | 0.23 | 0.20 | 0.19 | 0.21 | 0.22 |
| EBITDA | 6.86 Billion | 6.71 Billion | 6.3 Billion | 5.91 Billion | 4.83 Billion | 2.48 Billion |
| Earnings Before Tax Margin | 0.39 | 0.29 | 0.28 | 0.30 | 0.28 | 0.15 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 5.06 Billion | 5.88 Billion | 22.83 Billion | 5.36 Billion | 5.72 Billion | 5.95 Billion |
| Cost of Revenue | 2.25 Billion | 3.59 Billion | 10.02 Billion | 2.38 Billion | 2.42 Billion | 2.73 Billion |
| Gross Profit | 2.81 Billion | 2.29 Billion | 12.81 Billion | 2.97 Billion | 3.3 Billion | 3.22 Billion |
| Operating Expenses | 1.62 Billion | 844.98 Million | 6.6 Billion | 1.7 Billion | 1.71 Billion | 1.68 Billion |
| Selling, General and Administrative Expenses | 848.85 Million | 844.98 Million | - | 841.96 Million | 686.03 Million | 884.85 Million |
| Research and Development Expenses | - | - | - | - | 184 Million | - |
| Other Expenses | 1.62 Billion | 54.93 Million | 120.42 Million | 31.31 Million | 16.91 Million | 53.69 Million |
| Cost and Expenses | 3.87 Billion | 4.43 Billion | 16.62 Billion | 4.09 Billion | 4.13 Billion | 4.41 Billion |
| Operating Income | 1.19 Billion | 1.45 Billion | 6.32 Billion | 1.3 Billion | 1.59 Billion | 1.53 Billion |
| Interest Expense | 3.43 Million | 3.53 Million | 15.46 Million | 3.64 Million | 3.87 Million | 3.99 Million |
| Income Tax Expense | 321.4 Million | 387.55 Million | 1.6 Billion | 317.42 Million | 419.18 Million | 401.88 Million |
| Earnings before Tax | 1.27 Billion | 1.5 Billion | 6.31 Billion | 1.29 Billion | 1.6 Billion | 1.58 Billion |
| Net Income | 953.16 Million | 1.11 Billion | 4.7 Billion | 979.36 Million | 1.18 Billion | 1.18 Billion |
| Earnings Per Share Basic | 7.78 | 9.10 | - | 7.99 | 9.69 | 9.69 |
| Earnings Per Share Diluted | 7.75 | 9.08 | - | 7.99 | 9.67 | 9.69 |
| Weighted Average Shares Outstanding | 122.51 Million | 122.52 Million | 122.69 Million | 122.88 Million | 122.52 Million | 122.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 122.98 Million | 122.77 Million | 122.69 Million | 122.88 Million | 122.81 Million | 122.52 Million |
| Gross Margin | 0.56 | 0.39 | 0.56 | 0.56 | 0.58 | 0.54 |
| EBIT Margin | 0.28 | 0.27 | - | 0.27 | 0.30 | 0.29 |
| Profit Margin | 0.19 | 0.19 | 0.21 | 0.18 | 0.21 | 0.20 |
| EBITDA | 1.42 Billion | 1.59 Billion | - | 1.44 Billion | 1.74 Billion | 1.72 Billion |
| Earnings Before Tax Margin | 0.24 | 0.25 | 0.28 | 0.24 | 0.28 | 0.26 |
MTSA4
NOXL
TRAIN-B
MX1
ALFVY
PAYC